Ebrahim S. Delpassand
Expertise in
2
conditions

Dr. Ebrahim S. Delpassand

Radiology | Nuclear Medicine
9701 Richmond Ave, 
Houston, TX 
Accepting New Patients
Expertise in
2
conditions
9701 Richmond Ave, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ebrahim Delpassand is a Radiologist and a Nuclear Medicine provider in Houston, Texas. Dr. Delpassand is highly rated in 2 conditions, according to our data. His top areas of expertise are Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Pancreatic Ductal Adenocarcinoma, Lacrimal Gland Tumor, and Liver Embolization. Dr. Delpassand is currently accepting new patients.

His clinical research consists of co-authoring 28 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiology
Nuclear Medicine
Licenses
Nuclear Radiology in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

9701 Richmond Ave, Houston, TX 77042

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-label, Single-dose, Clinical Trial of 68Ga-DOTATATE (GalioMedix™) PET-CT Scan for Diagnosis of Primary and Metastatic Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
An Open-label, Single-dose, Clinical Trial of 68Ga-DOTATATE (GalioMedix™) PET-CT Scan for Diagnosis of Primary and Metastatic Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Enrollment Status: Completed
Publish Date: August 06, 2025
Intervention Type: Diagnostic test, Drug
Study Phase: Not Applicable
VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
VISION: An International, Prospective, Open Label, Multicenter, Randomized Phase 3 Study of 177Lu-PSMA-617 in the Treatment of Patients With Progressive PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug, Other
Study Drug: 177Lu-PSMA-617
Study Phase: Phase 3
A Phase II, Non-Randomized, Open-Label, Single-center, Physician Sponsored Study to Determine the Safety and Effectiveness of Lu-177 DOTATOC in Adult Subjects With Somatostatin Receptor Expressing Pulmonary, Pheochromocytoma, paragangliomUnknown Primary, and Thymus Neuroendocrine Tumors (PUTNET) or Any Other Non-.GEP-NET.
A Phase II, Non-Randomized, Open-Label, Single-center, Physician Sponsored Study to Determine the Safety and Effectiveness of Lu-177 DOTATOC in Adult Subjects With Somatostatin Receptor Expressing Pulmonary, Pheochromocytoma, paragangliomUnknown Primary, and Thymus Neuroendocrine Tumors (PUTNET) or Any Other Non-.GEP-NET.
Enrollment Status: Withdrawn
Publish Date: March 10, 2023
Intervention Type: Drug
Study Drug: 177Lu-DOTATOC
Study Phase: Phase 2
PSMA-directed endoRadiothErapy of Castration-reSISTant Prostate Cancer (RESIST-PC). A Phase II Clinical Trial
PSMA-directed endoRadiothErapy of Castration-reSISTant Prostate Cancer (RESIST-PC). A Phase II Clinical Trial
Enrollment Status: Terminated
Publish Date: March 24, 2021
Intervention Type: Drug
Study Phase: Phase 2
68Ga-PSMA (ProstaMedix™) PET-CT Scan for Diagnosis and Management of Prostate Cancer
68Ga-PSMA (ProstaMedix™) PET-CT Scan for Diagnosis and Management of Prostate Cancer
Enrollment Status: Unknown
Publish Date: August 19, 2020
Intervention Type: Drug
Study Drug: 68Ga-PSMA
Study Phase: Phase 2
View 4 Less Clinical Trials

28 Total Publications

Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Journal: Frontiers in oncology
Published: August 20, 2024
Similar Doctors
Expertise in
16
conditions
Dr. Jack P. Phan
Radiology | Radiation Oncology
Expertise in
16
conditions
Dr. Jack P. Phan
Radiology | Radiation Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (8.1 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances

Jack Phan is a Radiologist and a Radiation Oncologist in Houston, Texas. Dr. Phan is highly rated in 16 conditions, according to our data. His top areas of expertise are Olfactory Neuroblastoma, Laryngeal Cancer, Adenoid Cystic Carcinoma, Throat Cancer, and Gastrostomy.

Expertise in
7
conditions
Dr. Nghi C. Nguyen
Nuclear Medicine | Radiology
Expertise in
7
conditions
Dr. Nghi C. Nguyen
Nuclear Medicine | Radiology

MD Anderson

1515 Holcombe Blvd, 
Houston, TX 
 (8.7 miles away)
713-792-2121
Languages Spoken:
English
See accepted insurances

Nghi Nguyen is a Nuclear Medicine specialist and a Radiologist in Houston, Texas. Dr. Nguyen is highly rated in 7 conditions, according to our data. His top areas of expertise are Osteopenia, Melorheostosis, Melorheostosis with Osteopoikilosis, and Lung Nodules.

Expertise in
3
conditions
Dr. Beth Chasen
Nuclear Medicine | Radiology
Expertise in
3
conditions
Dr. Beth Chasen
Nuclear Medicine | Radiology

MD Anderson

2240 Gulf Fwy S, Utmb Health League City Ho, 
League City, TX 
 (31.5 miles away)
409-772-1011
Languages Spoken:
English
See accepted insurances

Beth Chasen is a Nuclear Medicine specialist and a Radiologist in League City, Texas. Dr. Chasen is highly rated in 3 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), T-Cell Lymphoma, Fibrolamellar Carcinoma, and Liver Embolization.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Delpassand's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile